Lithium Carbonate and Imipramine in Prevention of Affective Episodes: A Comparison in Recurrent Affective Illness
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Patients with recurrent affective illness (N-122) were randomly assigned to lithium carbonate, imipramine, or placebo therapy for two years following discharge from hospitalization for acute depression. Patients were classified as bipolar or unipolar based on the presence or absence of a history of mania. With bipolar patients lithium carbonate was significantly more effective than imipramine or placebo in preventing affective episodes (ie, manic or depressive attacks severe enough to require hospitalization or use of nonstudy drugs). There was a relatively high incidence of manic episodes on imipramine. Unipolar patients responded equally well to lithium carbonate or imipramine. Both treatments were significantly more effective than placebo. The difference between treatments was due primarily to depressive episodes; manic episodes occurred infrequently and were evenly distributed across treatment groups. There was no significant difference between lithium carbonate and imipramine among unipolar patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tricyclic antidepressant mono or adjunctive maintenance therapy is not recommended due to an increased risk of manic switch (level 2 negative)398, 399, 400”
Citations
Cites
(1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-971_2 · Cited by 705
Baastrup, P. C. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730200030005 · Cited by 570
Baastrup, P. C., Poulsen, J. C., Schou, M., Thomsen, K., & Amdisen, A. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92870-9 · Cited by 505
PROPHYLACTIC LITHIUM IN AFFECTIVE DISORDERS
Coppen, A., Noguera, R., Bailey, J., Burns, B. H., Swani, M. S., Hare, E. H., Gardner, R., & Maggs, R. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91331-6 · Cited by 363
Prien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750330035006 · Cited by 287
Self-citationPrien, R. F. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200050011 · Cited by 245
Self-citationLithium Response in Unipolar Versus Bipolar Depression
GOODWIN, F. K., MURPHY, D. L., DUNNER, D. L., & BUNNEY, W. E. (1972) · American Journal of Psychiatry · doi:10.1176/ajp.129.1.44 · Cited by 221
Dohan, F. C. (1966) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1966.tb01912.x · Cited by 164
Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders
Melia, P. I. (1970) · British Journal of Psychiatry · doi:10.1192/bjp.116.535.621 · Cited by 159
PROPHYLACTIC LITHIUM: ANOTHER THERAPEUTIC MYTH?
Blackwell, B., & Shepherd, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90917-3 · Cited by 158
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Affective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
“…or unspecified Unspecified 18 weeks ABA Calabrese et al. 2000 (30) 324 Both or unclear Rapid cycling Outpatient Unspecified 26 weeks RCT Imipramine Prien et al. 1973 (96)f 44 Outpatient Both or unclear Partial remission Unspecified 2 years RCT Kane et al. 1982 (100)f 22 Outpatients Bipolar II…”
BackgroundInfluentialPacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770
“An elevated risk of mood switching was first observed in early trials that compared imipramine monotherapy, lithium monotherapy, lithium plus imipramine, and placebo (18, 19).”
BackgroundCalabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0906 · Cited by 635
Cipriani, A., Pretty, H., Hawton, K., & Geddes, J. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1805 · Cited by 617
“Six of the 12 trials were informative for lithium versus placebo (18, 24, 31, 39, 40, 45), three for lithium versus tricyclic antidepressants (27, 28, 39), two for lithium versus carbamazepine (29, 30), and one for lithium versus lamotrigine (17).”
Antidepressant-induced mania and cycle acceleration: a controversy revisited
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1130 · Cited by 608
Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials
Gijsman, H. J., Geddes, J. R., Rendell, J. M., Nolen, W. A., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1537 · Cited by 563
“By contrast, the long-term use of antidepressants in bipolar patients may be associated with manic relapse (7, 8) and sometimes an increased frequency of bipolar episodes (rapid cycling) (9).”
BackgroundPrien, R. F. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220086014 · Cited by 565
Self-citationSuicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex
Goodwin, F. K. (2003) · JAMA · doi:10.1001/jama.290.11.1467 · Cited by 531
Ghaemi, S. N., Ko, J. Y., & Goodwin, F. E. I. K. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700202 · Cited by 456
Cognitive Therapy and Pharmacotherapy for Depression: Sustained Improvement Over One Year
Simons, A. D. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800010045006 · Cited by 438
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
“We identified only one study in Bipolar I patients where a antidepressant was used a priori as preventive treatment in euthymic patients (Prien et al 1973b).”
BackgroundResultRapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants
Wehr, T. A. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050065007 · Cited by 408
Can antidepressants cause mania and worsen the course of affective illness?
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1403 · Cited by 398
Antidepressants in bipolar disorder: the case for caution
Ghaemi, S. N., Hsu, D. J., Soldani, F., & Goodwin, F. K. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00074.x · Cited by 393
Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder
Suppes, T. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360046007 · Cited by 392
Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
“In a seminal maintenance study reported in 1973, manic episodes occurred in 12% of patients on lithium, 33% of patients on placebo, and 66% of patients on imipramine monotherapy (326).”
BackgroundThe Classification of Depressions: A Review of Contemporary Confusion
Kendell, R. E. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.129.1.15 · Cited by 385
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.11.1351 · Cited by 367
BLACKBURN, I., EUNSON, K., & BISHOP, S. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90050-9 · Cited by 338
Continuation drug therapy for major depressive episodes: how long should it be maintained?
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.18 · Cited by 295
Self-citationRisk Factors for Suicide in Psychiatric Patients
Roy, A. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090071014 · Cited by 293
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
“Few studies have directly compared the impact of antidepressant discontinuation versus continuation on the risk for depressive relapse after remission of an episode of bipolar depression (4, 5).”
BackgroundPredictors of Drug Response in Depression
Joyce, P. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010091014 · Cited by 280
Mania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., Miklowitz, D. J., Miyahara, S., Bauer, M. S., Thase, M. E., Wisniewski, S. R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.210 · Cited by 257
Viktorin, A., Lichtenstein, P., Thase, M. E., Larsson, H., Lundholm, C., Magnusson, P. K. E., & Landén, M. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13111501 · Cited by 246
Maj, M., Pirozzi, R., Magliano, L., & Bartoli, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.30 · Cited by 242
Lithium for maintenance treatment of mood disorders
Burgess, S. S., Geddes, J., Hawton, K. K., Taylor, M. J., Townsend, E., Jamison, K., & Goodwin, G. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003013 · Cited by 232
The Prophylactic Efficacy of Fluoxetine in Unipolar Depression
Montgomery, S. A., Dufour, H., Brion, S., Gailledreau, J., Laqueille, X., Ferrey, G., Moron, P., Parant-Lucena, N., Singer, L., Danion, J. M., et al. (1988) · British Journal of Psychiatry · doi:10.1192/s0007125000297328 · Cited by 232
Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A., & Watanabe, M. (1979) · Psychopharmacology · doi:10.1007/bf00428308 · Cited by 223
“, 1975) but also a prophylactic effect (Prien et al., 1973) on manic and depressive episodes has greatly contributed to the epoch-making”
BackgroundLeonard, H. L. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340054007 · Cited by 229
Grandjean, E. M., & Aubry, J.-M. (2009) · CNS Drugs · doi:10.2165/00023210-200923040-00005 · Cited by 203
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090053011 · Cited by 212
Young, L. T., Joffe, R. T., Robb, J. C., MacQueen, G. M., Marriott, M., & Patelis-Siotis, I. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.124 · Cited by 211
The suicide prevention effect of lithium: more than 20 years of evidence—a narrative review
Lewitzka, U., Severus, E., Bauer, R., Ritter, P., Müller-Oerlinghausen, B., & Bauer, M. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-015-0032-2 · Cited by 196
Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., Beasley, Jr., Michelson, D., Roback, P., & Sundell, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1247 · Cited by 204
Treatment of bipolar disorder: a systematic review of available data and clinical perspectives
Fountoulakis, K. N., & Vieta, E. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009231 · Cited by 169
“…suggested lithium was effective for the prophylaxis against both mania and bipolar depression (Dunner et al., 1976; Glen et al., 1984; Prien, 1984; Prien et al., 1973a,b, 1984), later studies suggest that lithium is effective in the prevention of manic episodes but possibly not for depressive…”
BackgroundResultInfluentialLong‐term antidepressant treatment in bipolar disorder: meta‐analyses of benefits and risks
Ghaemi, S. N., Wingo, A. P., Filkowski, M. A., & Baldessarini, R. J. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01257.x · Cited by 173
“1 1 Prien et al. 1973(38)[a] Prien et al. 1973 (38)[a] Prien et al. 1984 (41)[a] Prien et al. 1984 (41)[a]Prien et al. 1984 (41)[b] Prien et al. 1984 (41)[b] Johnstone et al. 1990 (42) Amsterdam et al. 2005 (43) Ghaemi et al. 2005 (44) Ghaemi et al. 2005 (44) (0.73 [0.55–0.97]) (1.72 [1.23–2.41])…”
BackgroundMethodInfluentialBaldessarini, R. J., Faedda, G. L., Offidani, E., Vázquez, G. H., Marangoni, C., Serra, G., & Tondo, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.033 · Cited by 169
Kishi, T., Ikuta, T., Matsuda, Y., Sakuma, K., Okuya, M., Mishima, K., & Iwata, N. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00946-6 · Cited by 169
Bipolar Depression: Overview and Commentary
Baldessarini, R. J., Vieta, E., Calabrese, J. R., Tohen, M., & Bowden, C. L. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747955 · Cited by 156
Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression
Gyulai, L., Bowden, C. L., McElroy, S. L., Calabrese, J. R., Petty, F., Swann, A. C., Chou, J. C.-Y., Wassef, A., Risch, C. S., Hirschfeld, R. M. A., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300190 · Cited by 165
Mundo, E., Walker, M., Cate, T., Macciardi, F., & Kennedy, J. L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.539 · Cited by 161
“(%)† None 12 (44) 16 (55) Obsessive-compulsive disorder 6 (22) 3 (10) Panic disorder 5 (19) 5 (17) Social phobia 3 (11) 1 (3) Simple phobia 0 1 (3) Alcohol abuse/dependence 2 (7) 1 (3) Substance abuse/dependence 1 (4) 1 (3) Posttraumatic stress disorder 1 (4) 2 (7) Generalized anxiety disorder 0 1 (3) Family history f…”
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham, L. N., Goldstein, J. M., Vieta, E., Bowden, C. L., Grunze, H., Post, R. M., Suppes, T. M., & Calabrese, J. R. (2005) · PubMed · Cited by 183
Old Age Depression Interest Group, Jacoby, R., Lunn, A. D., Ardern, M., Bergmann, K., Conway, J., Cooling, N., Davies, G., Fisk, J., Gehlhaar, E., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.2.175 · Cited by 155
Flupenthixol decanoate in recurrent manic‐depressive illness: A COMPARISON WITH LITHIUM
Ahlfors, U. G., Baastrup, P. C., Dencker, S. J., Elgen, K., Lingjærde, O., Pedersen, V., Schou, M., & Aaskoven, O. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00778.x · Cited by 155
The Induction of Mania: A Natural History Study With Controls
Lewis, J. L. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030041007 · Cited by 150
Placebos, Drug Effects, and Study Design: A Clinician’s Guide
Quitkin, F. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.829 · Cited by 149
Grunze, H., Kasper, S., Goodwin, G., Bowden, C., Mo¨ller, H.-J., & WFSBP Task Force on Treatment Guide (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029924 · Cited by 144
Fountoulakis, K. N., Tohen, M., & Zarate, C. A. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.10.003 · Cited by 146
The unipolar-bipolar distinction in the depressive disorders.
Depue, R. A., & Monroe, S. M. (1978) · Psychological Bulletin · doi:10.1037/0033-2909.85.5.1001 · Cited by 146
Effects of maintenance amitriptyline and psychotherapy on symptoms of depression
Paykel, E. S., Dimascio, A., Haskell, D., & Prusoff, B. A. (1975) · Psychological Medicine · doi:10.1017/s0033291700007236 · Cited by 144
Quitkin, F. M. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780330060006 · Cited by 146
Neurobiological correlates of illness progression in the recurrent affective disorders
Post, R. M., Fleming, J., & Kapczinski, F. P. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.02.004 · Cited by 154
Doris, A. B., Ebmeier, K. P., & Shajahan, P. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03121-9 · Cited by 177
Lithium Treatment and Prophylaxis in Unipolar Depression: A Meta-analysis
Souza, F. G. M., & Goodwin, G. M. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.5.666 · Cited by 144
The Bipolar Spectrum and the Antidepressant View of the World
GHAEMI, S. N., KO, J. Y., & GOODWIN, F. K. (2001) · Journal of Psychiatric Practice · doi:10.1097/00131746-200109000-00002 · Cited by 139
Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients
(1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.8.925 · Cited by 137
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry
Fountoulakis, K. Ν., Kasper, S. F., Andreassen, O. A., Blier, P., Okasha, A., Severus, E., Versiani, M., Tandon, R., Möller, H., & Vieta, E. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0323-x · Cited by 149
“Earlier studies pointed to this problem especially with tricyclics [399, 400, 403, 404]; however, this may not be the case with newer compounds.”
BackgroundResultInfluentialDunner, D. L. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770010073014 · Cited by 133
Post, R. M., Altshuler, L. L., Frye, M. A., Suppes, T., Rush, A. J., Keck, P. E., McElroy, S. L., Denicoff, K. D., Leverich, G. S., Kupka, R., et al. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030505.x · Cited by 113
Lithium Prophylaxis in Recurrent Affective Illness: Efficacy, Effectiveness and Efficiency
Guscott, R., & Taylor, L. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.741 · Cited by 130
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Caldecott‐Hazard, S., Morgan, D. G., DeLeon‐Jones, F., Overstreet, D. H., & Janowsky, D. (1991) · Synapse · doi:10.1002/syn.890090404 · Cited by 124
Mood stabilizers in the prevention of recurrent affective disorders: a meta‐analysis
Davis, J. M., Janicak, P. G., & Hogan, D. M. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10890.x · Cited by 120
Licht, R. W., Gijsman, H., Nolen, W. A., & Angst, J. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01237.x · Cited by 120
“(26), patients with bipolar disorder on imipramine had a higher rate of mania than those receiving placebo.”
BackgroundFountoulakis, K. N., Yatham, L., Grunze, H., Vieta, E., Young, A., Blier, P., Kasper, S., & Moeller, H. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw100 · Cited by 116
“There are 2 small, old negative studies concerning the efficacy of imipramine (Prien et al., 1973a; Kane et al., 1982), while on the contrary, 3 other small studies in BD-II patients provide some support for the usefulness of fluoxetine monotherapy in the prevention of depressive episodes…”
Charney, D. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.3.262 · Cited by 113
TREATMENT-RESISTANT BIPOLAR DEPRESSION
Sachs, G. S. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70285-9 · Cited by 113
The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior
Du, J., Creson, T. K., Wu, L.-J., Ren, M., Gray, N. A., Falke, C., Wei, Y., Wang, Y., Blumenthal, R., Machado-Vieira, R., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3080-07.2008 · Cited by 107
“We found that imipramine, which can provoke mania in humans (Prien et al., 1973, 1984), significantly enhanced GluR2 at synapses in hippocampus (control: 100 11.2%, n 7; imipramine: 131.6 7.23%, n 8; Student’s t test, p 0.033) (Fig.”
BackgroundInfluentialCoppen, A., Montgomery, S. A., Gupta, R. K., & Bailey, J. E. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.128.5.479 · Cited by 106
Rush, A. J., Trivedi, M. H., Carmody, T. J., Biggs, M. M., Shores‐Wilson, K., Ibrahim, H. M., & Crismon, M. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.005 · Cited by 113
Antidepressant-induced sexual dysfunction.
Segraves, R. T. (1998) · PubMed · Cited by 118
Alternatives to lithium for preventive treatment of bipolar disorder
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.7.840 · Cited by 107
Self-citationMood state at study entry as predictor of the polarity of relapse in bipolar disorder
Calabrese, J. R., Vieta, E., El‐Mallakh, R. S., Findling, R. L., Youngstrom, E. A., Elhaj, O., Gajwani, P., & Pies, R. W. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.022 · Cited by 108
Toward a Psychobiology of Transcendence: God in the Brain
Mandell, A. J. (1980) · Springer eBooks · doi:10.1007/978-1-4684-3456-9_14 · Cited by 121
Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions?
Dickson, W. E., & Kendell, R. E. (1986) · Psychological Medicine · doi:10.1017/s003329170001028x · Cited by 102
Possible role of antidepressants in precipitating mania and hypomania in recurrent depression
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.7.804 · Cited by 105
Amsterdam, J. D., & Justine Shults, A. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.02.018 · Cited by 101
Drugs Five Years Later: Lithium Salts: 1970-1975
Baldessarini, R., & Lipinski, J. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-527 · Cited by 69
Bipolar Mood Disorder: Practical Strategies for Acute and Maintenance Phase Treatment
SACHS, G. S. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604001-00005 · Cited by 98
Mandell, A. J., & Knapp, S. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780080083019 · Cited by 96
Clinical importance of long-term antidepressant treatment
Hirschfeld, R. M. A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.42.s4 · Cited by 90
Moncrieff, J. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.5.569 · Cited by 92
Lithium versus antidepressants in the long-term treatment of unipolar affective disorder
Cipriani, A., Smith, K. A., Burgess, S. S., Carney, S. M., Goodwin, G., & Geddes, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003492.pub2 · Cited by 91
Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01356.x · Cited by 90
“Using relapse rate as the principal outcome measure, three studies included only BD patients, or had separately randomised BD groups [36,194,195] (212 patients).”
BackgroundMethodA critical appraisal of lithium’s efficacy and effectiveness: the last 60 years
Grof, P., & Müller‐Oerlinghausen, B. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00707.x · Cited by 89
Lithium treatment for unipolar major depressive disorder: Systematic review
Undurraga, J. P., Sim, K., Tondo, L., Gorodischer, A., de Azúa, E. R., Tay, K. H., Tan, D. S. P., & Baldessarini, R. J. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118822161 · Cited by 93
Treatment of bipolar depression: An update
Fountoulakis, K. Ν., Grunze, H., Panagiotidis, P., & Kaprinis, G. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.10.016 · Cited by 93
Post, R. M., Denicoff, K. D., Frye, M. A., Dunn, R. T., Leverich, G. S., Osuch, E., & Speer, A. (1998) · Neuropsychobiology · doi:10.1159/000026532 · Cited by 87
Lithium: evidence reconsidered
Moncrieff, J. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.2.113 · Cited by 83
Geller, B., FOX, L. W., & FLETCHER, M. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199301000-00007 · Cited by 88
Greil, W., Ludwig‐Mayerhofer, W., Erazo, N., Engel, R. R., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Osterheider, M., Rudolf, G. A. E., Sauer, H., et al. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00070-5 · Cited by 84
Lithium: Updated Human Knowledge Using an Evidence-Based Approach
Grandjean, E. M., & Aubry, J. (2009) · CNS Drugs · doi:10.2165/00023210-200923030-00004 · Cited by 89
“In a more recent review by the International Consensus Group on Bipolar I Depression Treatment Guidelines,([67]) one placebo-controlled trial of lithium (published in the early 1970s) is reviewed([68]) in which lithium proved to be superior to placebo.”
BackgroundDiscontinuation of Maintenance Treatment in Bipolar Disorder: Risks and Implications
Suppes, T., Baldessarini, R. J., Faedda, G. L., Tondo, L., & Tohen, M. (1993) · Harvard Review of Psychiatry · doi:10.3109/10673229309017072 · Cited by 80
Continuation and maintenance therapy with antidepressive agents: Meta-analysis of research
Loonen, A. J. M., Peer, P. G. M., & Zwanikken, G. J. (1991) · Pharmaceutisch Weekblad Scientific Edition · doi:10.1007/bf01957741 · Cited by 79
Lithium: Still a Cornerstone in the Long-Term Treatment in Bipolar Disorder?
Nivoli, A., Murru, A., & Vieta, E. (2010) · Neuropsychobiology · doi:10.1159/000314307 · Cited by 89
Schou, M. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780080023006 · Cited by 79
Dopamine in manic depressive illness
Silverstone, T. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90020-5 · Cited by 77
Metadata
- Authors
- Prien, R. F.
- Corresponding author
- Prien, Robert F.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1973-09-01
- Volume
- 29
- Issue
- 3
- Pages
- 420
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2058662910
- Cited by
- 448
- References
- 19
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 9 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 7 · 2014: 6 · 2013: 4 · 2012: 6
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lithium carbonate, imipramine, bipolar disorder, major depressive disorder, manic episodes, depressive episodes, maintenance therapy, tricyclic antidepressants
- MeSH terms
- Adult, Affective Symptoms, Age Factors, Clinical Trials as Topic, Depression, Female, Hospitalization, Humans, Imipramine, Lithium, Male, Middle Aged, Placebos, Recurrence, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.